Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SANJIVANI PARANTERAL LTD.

NSE : NABSE : 531569ISIN CODE : INE860D01013Industry : Pharmaceuticals & DrugsHouse : Private

BSE247.4025.3 (+11.39 %)

PREV CLOSE ( ) 222.10

OPEN PRICE ( ) 223.75

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 32983

TODAY'S LOW / HIGH ( )217.60 254.00

52 WK LOW / HIGH ( ) 190396.95

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1994

Management Info

Ashwani Khemka - Chairman Ashwani Khemka - Managing Director

Registered Office

Address 205 P N Kothari Industrial Estate,L B S Marg,Bhandup (West),
Mumbai,
Maharashtra-400078

Phone 022-20812600

Email corporate@sanjivani.co.in

Website www.sanjivani.co.in

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE

NEWS

28May Sanjivani Paranteral informs about ear
Sanjivani Paranteral has informed that pursuant to Regulation 30 of the..

24Apr Sanjivani Paranteral informs about ini
Pursuant to the Circular Ref. No. SEBI/HO/DDHS/CIR/P/2018/144 dated Nove..

24Oct Sanjivani Paranteral informs about co
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

04Sep Sanjivani Parantera informs about boar
Sanjivani Parantera has informed that the meeting of the Board of Direct..

17Aug Sanjivani Paranteral informs about app
Pursuant to Regulation 06 of the SEBI (Listing Obligation and Disclosure..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	21.93	81.0099999999999
Gross Profit	26.61	103.59
Operating Profit	30.47	115.73
Net Sales	181.81	700.99

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Blue Jet Healthcare (BSE) 1012.00 (4.21%)	M.Cap ( in Cr)17554.70
Jubilant Pharmova (BSE) 1234.90 (2.87%)	M.Cap ( in Cr)19669.63
Mercury Laboratories (BSE) 888.00 (3.71%)	M.Cap ( in Cr)106.56
Abbott India (BSE) 34148.85 (0.06%)	M.Cap ( in Cr)72563.92
BDH Inds (BSE) 294.00 (7.14%)	M.Cap ( in Cr)169.26

Shareholding Pattern

	NON-INSTITUTION	64.98%
	PROMOTERS	28.87%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

SANJIVANI PARANTERAL LTD.